Cornerstone Therapeutics said that it has already begun a search for a successor.
Craig Collard, Cornerstone’s president and CEO, said: “I would like to thank Chenyqua for her significant contributions to Cornerstone over the past five years. Chenyqua has been an integral part of the growth of the company to date and we wish her success as she moves on to new challenges.”